Assemblée Nationale: Propose Commission Enquête Sénégal Accord Sanitaire US

• Senegal's National Assembly has launched an inquiry into a health agreement with the US, focusing on national personal data security.
• This agreement is part of the US "America First Global Health Strategy," which involves bilateral MoUs with 24 African nations.
• The US approach contrasts with the WHO's multilateral Pandemic Accord, which promotes equitable access to health resources.
• Other African countries like Ghana and Namibia have rejected similar US agreements due to concerns over national sovereignty and health data protection.
• The inquiry highlights potential long-term risks of data sharing, such as impacts on insurance, employment, and security targeting.

In an era marked by the rapid advancement of artificial intelligence and a perceived decline in the rule of law in international relations, the sharing of health data and information necessitates stringent regulation.

The Senegalese National Assembly is considering a proposed parliamentary inquiry into the bilateral health agreement between the Ministry of Health and the United States. This move, announced by the institution's president during the 2026-2027 ordinary session, specifically targets the safeguarding of national personal data within the framework of this memorandum of understanding. Senegal is one of twenty-four African countries that have entered into such bilateral protocols under the "America First Global Health Strategy Sénégal," a US initiative. The proposal for this "Commission enquête Sénégal accord sanitaire US" underscores growing concerns regarding the terms of international health data sharing.

This parliamentary action is part of a broader set of five public interest inquiries proposed by the National Assembly. The particular focus on the "Sénégal données santé accord États-Unis" highlights the sensitive nature of health information and the potential implications of its cross-border transfer. The inquiry aims to thoroughly examine the provisions related to data security and privacy, ensuring that national interests and individual rights are adequately protected within the scope of the agreement.

The bilateral approach favored by the United States, exemplified by the "America First Global Health Strategy Sénégal," stands in stark contrast to the multilateral framework promoted by the World Health Organization (WHO). In 2025, WHO member states adopted the Pandemic Accord, which includes a Pathogen Access and Benefit-Sharing (PABS) system designed to facilitate the rapid exchange of pathogen samples and sequencing data. This system aims to ensure more equitable access to vaccines, diagnostic tools, and other health countermeasures globally.

However, the United States has opted for a different path, having withdrawn from the WHO and the Pandemic Accord process. Washington now prioritizes bilateral agreements, often conditioning the resumption of its health assistance on specific obligations for pathogen data sharing. This shift forces individual nations, including Senegal, to negotiate terms under significant budgetary constraints and uncertainty regarding external aid, unlike a multilateral system where regional African blocs could collectively bargain for binding benefit-sharing rules. This dynamic raises questions about "Accord pandémies OMS bilatéral" approaches and their respective impacts on national sovereignty.

Concerns over national sovereignty and the "Protection données personnelles santé Afrique" are not unique to Senegal. Several other African nations, including Namibia and Ghana, have publicly declined to participate in the US strategy, citing similar reservations. Namibia, for instance, expressed significant apprehension regarding the implications of sharing health data and biological samples. Ghana specifically challenged American demands for access to its pathogenic profiles, which detail disease-causing agents present within the country, as well as certain patient medical records.

The full ramifications of sharing such sensitive health data may not be immediately apparent. Over time, however, these risks could manifest in various forms, impacting individuals and populations. Potential consequences include the exclusion of certain individuals from insurance mechanisms based on predictive analyses, the use of health risk scoring systems in recruitment or workforce management processes, or even the deployment of syndromic data to identify populations deemed "at risk" for security or border control operations. These scenarios underscore the critical importance of safeguarding "Sénégal souveraineté nationale données" and ensuring robust data protection frameworks.

In an era marked by the rapid advancement of artificial intelligence and a perceived decline in the rule of law in international relations, the sharing of health data and information necessitates stringent regulation. Such frameworks are crucial to guarantee the ethical, responsible, and non-commercial utilization of this highly sensitive information. Senegalese deputies are uniquely positioned to play a pivotal role in ensuring effective governance of health data, particularly through the ongoing "Commission enquête Sénégal accord sanitaire US."

The Senegalese Constitution, specifically Article 59, empowers members of parliament with the prerogative to oversee government actions and evaluate public policies. This constitutional mandate provides a strong basis for the current inquiry, enabling deputies to scrutinize the US-Senegal health agreement and its data provisions. Ultimately, promoting the swift finalization of the WHO's PABS annex for signing and ratification is considered a key step towards establishing robust health data governance, offering a multilateral alternative to purely bilateral arrangements.

Lawyers and compliance officers in Senegal should closely monitor the parliamentary inquiry into the US-Senegal health agreement. Its findings could lead to new regulations or interpretations regarding health data protection, national sovereignty, and the legal framework for international health data sharing, potentially creating new compliance obligations or litigation risks related to sensitive health information.

Source: Insights derived from legal news analysis.